Brain Health Supplements: Nootropics Surge in 2025

The Brain Health Supplements Market enters a dynamic phase in 2025, fueled by scientific advancements in nootropics and nutrient-focused formulations. As cognitive demands rise in professional and athletic spheres, these products address nutrient gaps to support mental clarity and performance. This article examines recent shifts, drawing from expert analyses to inform procurement and strategy decisions.

Brain Health Supplements Market: Key Developments in 2024–2025

Recent research underscores the expanding role of brain health supplements. A 2024 meta-analysis of 16 studies in Frontiers in Nutrition found that creatine supplementation significantly improves memory and information processing in adults, though effects on attention remain mixed. This builds on a 2024 review in Behavioural Brain Research, which noted mixed but promising results for creatine in deficient populations, such as the elderly and sleep-deprived.

Emerging reviews in active nutrition research suggest that arginine-inositol silicate may support cognitive performance, but findings remain preliminary and require further clinical validation. Citicoline emerged as a key precursor for choline, aiding neuronal function and ATP production for attention. Meanwhile, neurologists emphasize the importance of full vitamin B-complex intake—particularly folate and B12—for populations at risk of deficiency, with studies such as VITACOG showing slowed brain shrinkage in older adult.

These findings reinforce evidence-based positioning for brain health supplements, increasing consumer trust and driving new formulation investments, particularly among B2B buyers seeking clinically validated ingredients.

Applications Across Industries

Brain health supplements extend beyond individual wellness, integrating into diverse industries to enhance productivity and resilience.

• Sports and Active Nutrition: Nootropics like tyrosine support executive function in sleep-deprived athletes and military personnel, improving reaction time under stress. Creatine mitigates sleep deprivation effects via mitochondrial activation, aiding recovery drinks and bars.

• Corporate Wellness and Pharmaceuticals: B-complex vitamins facilitate neurotransmitter synthesis, reducing fatigue in high-stress offices; clinical applications target neurodegenerative diseases and depression. Creatine shows prophylactic potential for traumatic brain injury in executive health programs.

• Food and Beverage: Fortified cereals and nutritional yeast deliver B-vitamins naturally, while gummies and energy bars incorporate creatine for on-the-go cognitive support.

This cross-industry adoption creates supply chain opportunities, as buyers seek versatile formulations compliant with regulatory standards.

Analysis of Dominating and Fastest-Growing Regions

The brain health supplements market shows regional disparities, with North America maintaining dominance due to established research infrastructure and consumer awareness. The U.S. nootropics segment, valued under $4 billion in 2022, projects to nearly $12 billion by 2030, driven by events like "The Outlook on Active Nutrition" and studies from institutions such as Nova Southeastern University. 

The U.S. remains the leading market in North America, with magnesium and vitamin D deficiencies continuing to be linked to cognitive health risks—factors that support rising consumer demand for brain-supporting supplements.

North America dominates with 40%+ market share implied by U.S. projections, while Asia-Pacific grows fastest at 8–10% CAGR, propelled by dietary shifts and trials like FACT. Europe balances with regulatory support for claims. For industrial buyers, this signals sourcing from U.S. innovators for premium products and Asian partners for cost-effective scaling.

Key Players and Recent Strategies/Deals

Leading and emerging companies leverage 2024–2025 science for targeted innovations, focusing on brain-specific formulations.

• Momentous (Emerging Leader): Emphasizes creatine's neuroprotective role in its Creatine Monohydrate product, launched with brain health claims in 2022 and updated via 2024 meta-analysis integrations. CEO Jeff Byers noted cognitive benefits realization "three or four years ago," positioning it for executives and seniors; bundled in the Three pack for $130. Advisory board additions like Andrew Huberman in 2022 drive mental health advocacy.

• Thorne Research (Established Player): Integrates creatine as a cornerstone in nootropic stacks, spotlighting 2024 memory improvements; strategies include third-party certification for clinical credibility.

• Onnit (Leading Innovator): Features creatine in recovery formulas, linking to sleep deprivation mitigation from 2023–2024 studies; recent push into gummies for broader accessibility.

• Substantiation Sciences (Research-Driven Emerging): Co-founded by Douglas Kalman, advances arginine-inositol silicate validation for acute cognitive enhancement, as presented in 2025; focuses on substantiation for sports nutrition deals.

These strategies—tied to product pages—enhance market positioning by aligning with verified trials, enabling B2B deals like co-formulation partnerships. No major 2024–2025 mergers noted, but influencer collaborations amplify reach.

Other notable companies in the industry include Purelife Bioscience Co. Ltd, NOW Foods, Quincy Bioscience, Teva Pharmaceutical Industries Ltd., Endurance Products Company, Ketone-IQ, and more.

Future Prospects and Examples

The brain health supplements market holds robust prospects, with nootropics projected to triple to $12 billion by 2030 amid aging populations and stress epidemics. Experts like Shawn Arent, PhD, suggest that creatine’s cognitive and neuroprotective potential may eventually place it alongside multivitamins as part of an overall wellness plan. Yet again, Next Move Strategy Consulting (NMSC), in its recent research report pointed the sector to hit USD 19.53 billion by 2030 with a CAGR of 11.9%.

Examples include B-complex fortified bars for corporate fleets, reducing fatigue 10–15% in trials, or citicoline prenatal supplements addressing 40% iron deficiency risks. For buyers, this forecasts 15% annual growth in customized blends, emphasizing sustainable sourcing to meet EU green claims.

About Next Move Strategy Consulting: 

Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes NMSC different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more information, please contact: 

Next Move Strategy Consulting 

5th Floor 867 

Boylston St, STE 500, 

Boston, MA 02116, U.S. 

E-Mail: [email protected]

Direct: +18577585017 

Website: www.nextmsc.com